Denali Therapeutics Inc. DNLI Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s operating lease right-of-use assets in other assets?
- Denali Therapeutics Inc. (DNLI) reported operating lease right-of-use assets in other assets of $17.92M in Q1 2026.
- How has Denali Therapeutics Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Denali Therapeutics Inc.'s operating lease right-of-use assets in other assets decreased by 18.4% year-over-year, from $21.96M to $17.92M.
- What is the long-term trend for Denali Therapeutics Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s operating lease right-of-use assets in other assets has grown at a -10.2% compound annual growth rate (CAGR), from $32.62M to $19M.